approved EB-1A
Senior Scientist
Analytical Chemistry · China · 2025-05-29
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.
Framework Evaluation
3 of 3 criteria metScholarly Articles (Met)
The petitioner authored 8 articles in high-impact journals such as Nature Microbiology (IF 20.5) and Nature Chemical Biology (IF 13.0).
Judging (Met)
The petitioner completed over 20 peer reviews for prestigious journals, demonstrating his status as an authority in the field.
Original Contributions (Met)
The petitioner's work in small molecule isolation and structure elucidation has been cited 260 times and utilized by global research institutions to develop new therapeutic analogs.
Why This Petition Was Approved
The petition was approved based on the satisfaction of at least three EB-1A criteria: authorship of scholarly articles, participation as a judge of the work of others, and original scientific contributions of major significance. Specific metrics included 8 peer-reviewed publications in elite journals like Nature Microbiology, 260 citations placing him in the top 1% of his field, and the completion of over 20 peer reviews for high-impact journals.
Evidence
Evidence Types
Peer Reviewed Publications
Citations
Grants
Judging Experience
Original Contributions
Government Alignment
Evidence Submitted
- 8 peer-reviewed journal publications including Nature Microbiology and Nature Chemical Biology
- 260 citations with an h-index of 7
- Over 20 peer reviews for journals such as Journal of Natural Products and Molecules
- Evidence of research funding from NIH, Bill & Melinda Gates Foundation, and NSERC
- Documentation of work being replicated by institutions like Scripps Research and University of Groningen
- Top 1% most-cited researcher status in drug design
Similar Cases
Scientist
Pharmaceuticals · India
WeGreened EB-1A approved
Massachusetts 410 days 2025-10-06
The petition was approved based on the petitioner's authorship of 27 peer-reviewed articles and 17 abstracts, which garnered 485 citations from researchers in over 40 countries. His work ranked in the top 10% of most-cited publications in pharmacology for several years. Additionally, he completed over 60 peer reviews and received research grants from the NIH and the National Research Foundation of South Korea.
Postdoctoral Researcher
Pharmaceuticals · Pakistan
WeGreened EB-1A approved
New York 90 days 2025-02-07
The petition was approved based on meeting at least three EB-1A criteria: authorship of scholarly articles, participation as a judge of others' work, and original scientific contributions of major significance. Specific metrics included 34 journal articles in high-impact venues like Cell Chemical Biology, 1,306 citations with an h-index of 17, and over 25 completed manuscript reviews. Evidence of the commercialization of key compounds further demonstrated the petitioner's extraordinary ability.
Director
Chemicals · China
WeGreened EB-1A approved
Massachusetts 16 days 2025-06-12
The petition was approved based on meeting at least three EB-1A criteria: authorship of 13 peer-reviewed journal articles and a conference paper, serving as a reviewer for at least 12 manuscripts, and demonstrating original contributions through 254 citations from 27 countries. Additionally, the petitioner secured significant research funding from the FDA, USP, and NSF, further validating his leading role and expertise.
Chemist
Pharmaceuticals · India
WeGreened EB-1A rfe approved
Florida 553 days 2025-09-09
The petition was approved based on 27 peer-reviewed journal articles and 567 citations, placing the petitioner in the top 1% of researchers in his field. Additionally, he completed 61 peer reviews for top-tier journals and served on editorial boards, satisfying the EB-1A criteria for scholarly articles, judging, and original contributions.
Frequently Asked Questions
A approved EB-1A (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.
Browse More Cases
Case data sourced from publicly available petition decisions and case studies. Decision date: 2025-05-29.
Browse all casesAt a Glance
Outcome approved
Processing 21 days
Criteria Met 3 / 3
Evidence Types 6
EB-1A Case Data
Scraped Case Data
Total Cases 881
Success Rate 52.9%
Sustained 466
Dismissed 299
Related Pages
Get Case Insights
Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.
Join Waitlist